Evidence map›Paper›PMID 41293187›Full record

ArticleFrontiers in nutrition2025

The anti-allergic effect of

Pei Zhao, Bin Zhang, Lian S Zhao, Zhongli Yang, Ming D Li

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pei ZhaoCollege of Life Sciences, Shanxi Agricultural University-Taigu Campus, Jinzhong, China.
Bin ZhangState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Lian S ZhaoFrontage Laboratories Inc., Suzhou, Jiangsu, China.
Zhongli YangState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ming D LiCollege of Life Sciences, Shanxi Agricultural University-Taigu Campus, Jinzhong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Current treatment strategies for Allergic rhinitis (AR) are often limited by adverse effects and less efficacy. This study aims to evaluate the therapeutic effect of Methods: Mice were sensitized intraperitoneally with RAGW or HDM on days 0, 7, and 14, followed by daily intranasal challenges with the respective allergen from day 21 to day 49. The treatment group mice were orally administered cetirizine (10 mg/kg) as positive control or three different doses of Results: In both RAGW- and HDM-induced AR models, Conclusion: This study demonstrated the

Indexed as

allergic rhinitisIgELactobacillus plantarum GUANKETh2 cytokinestreatment

Identifiers

PMID41293187
PMCPMC12641390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.